Kähkönen TE, Galabova G, Yang R, Wen J, Thormann M, Halleen JM 2025 A highly potent selective CDK9 inhibitor OBP-004 reduces metastatic tumor burden in bone, brain, lung and lymph nodes and decreases growth of triple-negative breast cancer cells in bone. Cancer Res 85 (8_Supplement_1):3012. AACR Annual Meeting, April 25-30, 2025, Chicago, IL.
If you are interested to learn more,
see our services or contact us directly.
